Two weeks of low-dose JWH-018 in rats produced persistent cardiovascular stimulation, cardiac lesions, mitochondrial dysfunction in heart cells, and multi-organ damage that persisted or worsened after the drug was stopped.
Emergency physicians, cardiologists treating synthetic cannabinoid users, and toxicologists.
Cardiac and multi-organ damage persisted and worsened even after stopping JWH-018
What the researchers found
Repeated JWH-018 at 0.25 mg/kg for 14 days caused persistent hypothermia, increased blood pressure and heart rate throughout treatment. One day after stopping, cardiac lesions (vacuolization, waving, edema) were found. Seven days later, lung, kidney, and liver degeneration appeared. Heart mitochondria showed defective lipid oxidation, suggesting a mechanism for JWH-018's cardiac toxicity.
Why it matters
This study demonstrates that even low doses of a common synthetic cannabinoid can cause lasting organ damage, particularly to the heart. The finding that damage worsens after stopping the drug suggests ongoing pathological processes that outlast drug exposure.
The numbers in context
JWH-018 dose: 0.25 mg/kg for 14 days; cardiac lesions at day 1 post-discontinuation; multi-organ damage at day 7; mitochondrial dysfunction in cardiomyocytes; in silico screening of 36 SCRAs
How the study worked
In silico toxicity screening of 36 synthetic cannabinoids, followed by 14-day repeated dosing of JWH-018 (0.25 mg/kg IP) in male rats, with cardiovascular monitoring during treatment and post-mortem tissue analysis at 1 and 7 days after discontinuation.
What this study cannot tell us
Animal study with a single synthetic cannabinoid and dose level. IP injection does not mimic human smoking/vaping routes. Only male rats studied. Short treatment period relative to human use patterns.
How to read the evidence
Comprehensive animal study combining in silico, in vivo, and ex vivo approaches, but limited to one compound and dose.
When this study was published
Published in 2024.
The bigger picture
Reports of sudden cardiac deaths among synthetic cannabinoid users have been increasing. This study provides a biological mechanism (mitochondrial dysfunction) and shows that damage can progress even after stopping use, which has important clinical implications.
Questions still open
- Would cardiac damage from JWH-018 be reversible with longer recovery periods?
- Do other commonly used synthetic cannabinoids produce similar cardiac toxicity?
Common questions
Can synthetic cannabinoids damage the heart?
Is the damage reversible?
Read the original research
Evidence for enduring cardiac and multiorgan toxicity after repeated exposure to the synthetic cannabinoid JWH-018 in male rats.
Toxicology, 507, 153878
Citation
Pintori, Nicholas; Serra, Maria Pina; Carai, Antonio; Lobina, Carla; Isola, Raffaella; Noli, Roberta; Piras, Gessica; Spano, Enrica; Baumann, Michael H; Quartu, Marina; De Luca, Maria Antonietta. (2024). Evidence for enduring cardiac and multiorgan toxicity after repeated exposure to the synthetic cannabinoid JWH-018 in male rats.. Toxicology, 507, 153878. https://doi.org/10.1016/j.tox.2024.153878
Explore the wider topic
- THC Purity and Potency: What the Label Actually Means
- Dab and Concentrate Withdrawal: Why It Hits Harder
- Delta-8 THC: Addiction, Withdrawal, and What We Don't Know
- Edible Addiction and Withdrawal: What Makes It Different
- Edibles and Psychosis: When a Bad Trip Becomes an Emergency
- Vaping vs Smoking vs Edibles: A Harm Reduction Guide
- How Cannabis Products Are Made: From Plant to Concentrate to Edible
- Laced Weed and Contaminated Vapes: Real Risks vs Myths
- Legal vs Street Weed: Quality, Safety, and What You're Actually Smoking
- Quitting Weed Pens and Dabs: Why Concentrates Hit Different
- Quitting Edibles: Is Withdrawal Different from Smoking?
- Sativa vs Indica: The Myth and the Science Behind Cannabis Strain Labels
- Why Is Weed Withdrawal Worse Now Than 20 Years Ago?